Hemodynamic Monitoring for Heart Failure Patients

Academic Content

Program Overview

Faculty Presentations

Introduction Akshay S. Desai MD, MPH William T. Abraham, MD

Faculty Roundtable Discussion

Presentation Notes and References

Current Activity

Faculty Roundtable Discussion

Return to:

The American Journal of Cardiology

« Prev Activity

Statement 1

True or Not True: Symptomatic heart failure patients remain symptomatic primarily because of low cardiac output.

Statement 2

True or Not True: The principal goal of heart failure drug treatment is optimizing neurohormonal therapies.

Statement 3

True or Not True: Monitoring symptoms and daily weights is adequate for managing heart failure congestion.

True or Not True: Biomarkers and implantable electronic monitoring devices have been developed as a means to keep heart failure patients out of the hospital — but they haven't proven to be really useful clinically.

Statement 5

True or Not True: Currently there is no effective therapy for heart failure with preserved left ventricular ejection fraction (also known as diastolic heart failure).

Statement 6

True or Not True: Adding another whole category of heart failure information that applies on a patient-by-patient basis is going to mean adding an entire new category of staffing and record keeping to my practice.